Journal Image
Recent Patents on DNA & Gene Sequences
ISSN (Print): 1872-2156
ISSN (Online): 2212-3431
DOI: 10.2174/187221512802717394

Genetic Enhancement in Sport: Just Another Form of Doping?

Author(s): Maxwell J. Mehlman
Pages 240-246 (7)
Patented genetic technologies such as the ACTN3 genetic test are adding a new dimension to the types of performance enhancement available to elite athletes. Organized sports organizations and governments are seeking to prevent athletes’ use of biomedical enhancements. This paper discusses how these interdiction efforts will affect the use and availability of genetic technologies that can enhance athletic performance. The paper provides a working definition of enhancement, and in light of that definition and the concerns of the sports community, reviews genetic enhancement as a result of varied technologies, including, genetic testing to identify innate athletic ability, performance-enhancing drugs developed with genetic science and technology, pharmacogenetics, enhancement through reproductive technologies, somatic gene transfer, and germ line gene transfer.
Genetic, enhancement, sports, genetic testing, olympics, world anti-doping association, in vitro fertilization, preimplantation genetic diagnosis, genetic information nondiscrimination act, recombinant DNA
Arthur E. Petersilge Professor of Law, Director, The Law-Medicine Center, Case Western Reserve University School of Law, Professor of Biomedical Ethics, Case Western Reserve University School of Medicine